Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hyperlipoproteinemia Type II | 15 | 2021 | 123 | 6.60 | Why? |
| Mast Cells | 9 | 2019 | 370 | 1.91 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2021 | 1510 | 1.79 | Why? |
| Lipoprotein(a) | 4 | 2021 | 92 | 1.76 | Why? |
| Anticholesteremic Agents | 3 | 2020 | 186 | 1.46 | Why? |
| Cholesterol | 9 | 2018 | 660 | 0.94 | Why? |
| Lipoproteins | 4 | 2021 | 240 | 0.94 | Why? |
| Cholesterol, LDL | 4 | 2020 | 499 | 0.89 | Why? |
| Proprotein Convertase 9 | 2 | 2021 | 141 | 0.83 | Why? |
| Apolipoprotein A-I | 4 | 2018 | 148 | 0.82 | Why? |
| Sitosterols | 1 | 2018 | 7 | 0.79 | Why? |
| Arteries | 2 | 2019 | 283 | 0.78 | Why? |
| Hypolipidemic Agents | 2 | 2017 | 208 | 0.74 | Why? |
| Blood Component Removal | 1 | 2021 | 175 | 0.74 | Why? |
| Heat-Shock Proteins | 1 | 2021 | 226 | 0.73 | Why? |
| Endothelium, Vascular | 5 | 2021 | 1751 | 0.72 | Why? |
| Tyrosine | 1 | 2018 | 66 | 0.72 | Why? |
| Chymases | 2 | 2018 | 86 | 0.71 | Why? |
| Hypercholesterolemia | 2 | 2018 | 175 | 0.69 | Why? |
| Atherosclerosis | 4 | 2018 | 768 | 0.68 | Why? |
| Substance P | 1 | 2017 | 23 | 0.67 | Why? |
| Lipoproteins, LDL | 6 | 2018 | 115 | 0.65 | Why? |
| Cholesterol, HDL | 5 | 2018 | 439 | 0.65 | Why? |
| Triglycerides | 2 | 2019 | 478 | 0.64 | Why? |
| Lipids | 4 | 2019 | 1079 | 0.61 | Why? |
| Calcinosis | 1 | 2018 | 240 | 0.61 | Why? |
| Proteolysis | 2 | 2018 | 751 | 0.57 | Why? |
| Sinus Thrombosis, Intracranial | 1 | 2021 | 550 | 0.56 | Why? |
| Heterozygote | 4 | 2018 | 249 | 0.52 | Why? |
| Foam Cells | 2 | 2010 | 21 | 0.50 | Why? |
| Anti-Obesity Agents | 3 | 2017 | 52 | 0.50 | Why? |
| Aortic Valve | 1 | 2018 | 664 | 0.47 | Why? |
| Lipoproteins, HDL | 5 | 2018 | 154 | 0.46 | Why? |
| Mucormycosis | 1 | 2021 | 832 | 0.46 | Why? |
| ATP-Binding Cassette Transporters | 1 | 2010 | 48 | 0.42 | Why? |
| Aortic Valve Stenosis | 1 | 2018 | 741 | 0.41 | Why? |
| Myocardium | 2 | 2018 | 2323 | 0.38 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.35 | Why? |
| Carotid Artery Diseases | 3 | 2018 | 251 | 0.34 | Why? |
| Aneurysm, Ruptured | 2 | 2018 | 109 | 0.34 | Why? |
| Lactones | 2 | 2017 | 62 | 0.33 | Why? |
| Cardiovascular Diseases | 4 | 2020 | 11497 | 0.31 | Why? |
| Carotid Arteries | 2 | 2018 | 182 | 0.31 | Why? |
| Eosinophilia | 1 | 2009 | 292 | 0.31 | Why? |
| Proteoglycans | 3 | 2018 | 130 | 0.30 | Why? |
| Conjunctivitis | 1 | 2009 | 318 | 0.29 | Why? |
| Tryptases | 2 | 2019 | 37 | 0.26 | Why? |
| Eosinophils | 1 | 2009 | 848 | 0.25 | Why? |
| Intracranial Aneurysm | 2 | 2018 | 504 | 0.25 | Why? |
| Cranial Sinuses | 1 | 2021 | 38 | 0.23 | Why? |
| Endarterectomy, Carotid | 2 | 2018 | 78 | 0.22 | Why? |
| Homozygote | 2 | 2021 | 230 | 0.21 | Why? |
| Erythrocytes | 3 | 2018 | 617 | 0.21 | Why? |
| Upstream Stimulatory Factors | 1 | 2018 | 1 | 0.20 | Why? |
| Hyperlipidemia, Familial Combined | 1 | 2018 | 5 | 0.20 | Why? |
| Coronary Artery Disease | 3 | 2019 | 2570 | 0.19 | Why? |
| Cathepsin G | 1 | 2018 | 2 | 0.19 | Why? |
| Apolipoprotein B-100 | 1 | 2018 | 18 | 0.19 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.18 | Why? |
| Nerve Degeneration | 1 | 2018 | 73 | 0.18 | Why? |
| Liver X Receptors | 1 | 2017 | 13 | 0.18 | Why? |
| Phytosterols | 1 | 2017 | 22 | 0.17 | Why? |
| Phagocytosis | 2 | 2018 | 409 | 0.17 | Why? |
| Cell Hypoxia | 1 | 2018 | 141 | 0.17 | Why? |
| Inflammation | 3 | 2019 | 13255 | 0.17 | Why? |
| Brain Infarction | 1 | 2018 | 129 | 0.17 | Why? |
| Intestinal Absorption | 1 | 2017 | 64 | 0.17 | Why? |
| Plaque, Atherosclerotic | 2 | 2018 | 423 | 0.16 | Why? |
| ATP Binding Cassette Transporter 1 | 2 | 2018 | 17 | 0.16 | Why? |
| Biological Transport | 4 | 2017 | 290 | 0.16 | Why? |
| Mastocytosis | 1 | 2017 | 80 | 0.16 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.15 | Why? |
| Humans | 46 | 2021 | 930598 | 0.15 | Why? |
| Carotid Stenosis | 1 | 2018 | 207 | 0.15 | Why? |
| Animals | 14 | 2019 | 78931 | 0.14 | Why? |
| Body Weight | 2 | 2017 | 1074 | 0.14 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.13 | Why? |
| Obesity | 4 | 2018 | 7388 | 0.13 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.12 | Why? |
| Cells, Cultured | 5 | 2018 | 5835 | 0.12 | Why? |
| Rats | 3 | 2018 | 2764 | 0.12 | Why? |
| Angiotensin II | 1 | 1998 | 601 | 0.12 | Why? |
| Cytoplasmic Granules | 2 | 1989 | 53 | 0.12 | Why? |
| Macrophages | 3 | 2018 | 2784 | 0.12 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.11 | Why? |
| Lipoproteins, HDL2 | 1 | 2010 | 1 | 0.11 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.11 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Serine Endopeptidases | 2 | 2002 | 4606 | 0.10 | Why? |
| Cell Count | 1 | 2009 | 228 | 0.10 | Why? |
| Research Design | 3 | 2020 | 5830 | 0.09 | Why? |
| Goblet Cells | 1 | 2009 | 181 | 0.09 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.09 | Why? |
| Skin Tests | 1 | 2009 | 229 | 0.09 | Why? |
| Life Style | 1 | 2021 | 2708 | 0.09 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.09 | Why? |
| Apolipoproteins B | 1 | 1987 | 47 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.08 | Why? |
| Platelet-Derived Growth Factor | 1 | 2006 | 21 | 0.08 | Why? |
| Synovial Membrane | 1 | 2006 | 72 | 0.08 | Why? |
| Hydrogen-Ion Concentration | 1 | 2010 | 993 | 0.08 | Why? |
| Carotid Artery, Internal | 1 | 2007 | 97 | 0.08 | Why? |
| Protein Structure, Secondary | 1 | 2010 | 1077 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.08 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.07 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.07 | Why? |
| Finland | 2 | 2018 | 671 | 0.07 | Why? |
| Kinetics | 2 | 2010 | 3238 | 0.07 | Why? |
| Down-Regulation | 1 | 2010 | 1416 | 0.07 | Why? |
| Lipoproteins, HDL3 | 1 | 2002 | 2 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.07 | Why? |
| Apolipoproteins A | 1 | 2002 | 19 | 0.07 | Why? |
| Biological Transport, Active | 1 | 2002 | 46 | 0.06 | Why? |
| Tunica Intima | 1 | 2002 | 27 | 0.06 | Why? |
| Piperazines | 1 | 2006 | 445 | 0.06 | Why? |
| Fibroblasts | 1 | 2006 | 839 | 0.06 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.06 | Why? |
| Protein Isoforms | 1 | 2002 | 347 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Weight Loss | 2 | 2017 | 826 | 0.06 | Why? |
| Peptide Hydrolases | 1 | 1989 | 1269 | 0.06 | Why? |
| Extracellular Matrix | 1 | 2002 | 189 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Registries | 1 | 2021 | 12327 | 0.05 | Why? |
| Female | 12 | 2018 | 380317 | 0.05 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.05 | Why? |
| Biopsy | 1 | 2009 | 2811 | 0.05 | Why? |
| Risk Assessment | 3 | 2018 | 25439 | 0.05 | Why? |
| In Vitro Techniques | 2 | 1998 | 1027 | 0.05 | Why? |
| Aorta | 1 | 2002 | 355 | 0.05 | Why? |
| Mice | 4 | 2018 | 21357 | 0.05 | Why? |
| Male | 13 | 2018 | 367725 | 0.05 | Why? |
| Macrophages, Peritoneal | 1 | 2018 | 38 | 0.05 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.05 | Why? |
| c-Mer Tyrosine Kinase | 1 | 2018 | 11 | 0.05 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2018 | 17 | 0.05 | Why? |
| Lipolysis | 1 | 2017 | 12 | 0.05 | Why? |
| Milk Proteins | 1 | 2018 | 47 | 0.05 | Why? |
| Muscle, Smooth | 1 | 2018 | 67 | 0.05 | Why? |
| Calreticulin | 1 | 2018 | 38 | 0.04 | Why? |
| Extracellular Space | 1 | 2017 | 26 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| CD47 Antigen | 1 | 2018 | 47 | 0.04 | Why? |
| Pyrimidines | 1 | 2006 | 1557 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2017 | 10649 | 0.04 | Why? |
| Cell Degranulation | 1 | 2018 | 130 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Puberty | 1 | 2017 | 53 | 0.04 | Why? |
| Magnetic Resonance Angiography | 1 | 2018 | 282 | 0.04 | Why? |
| Antigens, Surface | 1 | 2018 | 181 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Brachial Artery | 1 | 2017 | 107 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2018 | 389 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2017 | 179 | 0.04 | Why? |
| RNA, Messenger | 1 | 2010 | 5131 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Cell Death | 1 | 2018 | 536 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2017 | 605 | 0.04 | Why? |
| Creatine Kinase | 1 | 2017 | 386 | 0.04 | Why? |
| Vasodilation | 1 | 2017 | 258 | 0.04 | Why? |
| Peptides | 1 | 2007 | 2513 | 0.04 | Why? |
| Gene Expression Regulation | 1 | 2007 | 4020 | 0.03 | Why? |
| Adult | 7 | 2018 | 244371 | 0.03 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.03 | Why? |
| Heparin | 1 | 1987 | 2600 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Hydroxychloroquine | 1 | 2017 | 12447 | 0.03 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.03 | Why? |
| Resins, Plant | 1 | 1992 | 9 | 0.03 | Why? |
| Child | 3 | 2018 | 70012 | 0.03 | Why? |
| Genes, Dominant | 1 | 1992 | 18 | 0.03 | Why? |
| Arthritis, Rheumatoid | 1 | 2006 | 2043 | 0.03 | Why? |
| Receptors, LDL | 1 | 1992 | 42 | 0.03 | Why? |
| Iron | 1 | 2018 | 619 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2018 | 88759 | 0.03 | Why? |
| Adipose Tissue | 1 | 1977 | 612 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.03 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Cholesterol Esters | 1 | 1989 | 2 | 0.03 | Why? |
| Sulfur Radioisotopes | 1 | 1989 | 5 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2017 | 1394 | 0.03 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.03 | Why? |
| Carbon Radioisotopes | 1 | 1989 | 35 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.03 | Why? |
| Cardiovascular System | 1 | 2017 | 750 | 0.02 | Why? |
| Iodine Radioisotopes | 1 | 1989 | 124 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.02 | Why? |
| Perilipin-2 | 1 | 2007 | 7 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Polysaccharide-Lyases | 1 | 1987 | 4 | 0.02 | Why? |
| Rats, Inbred Strains | 1 | 1987 | 14 | 0.02 | Why? |
| Heparin Lyase | 1 | 1987 | 7 | 0.02 | Why? |
| Exocytosis | 1 | 1987 | 34 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Protein Binding | 2 | 2018 | 11430 | 0.02 | Why? |
| Macromolecular Substances | 1 | 1987 | 103 | 0.02 | Why? |
| Crystallization | 1 | 2007 | 331 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.02 | Why? |
| Coronary Disease | 1 | 1992 | 645 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Necrosis | 1 | 2007 | 532 | 0.02 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.02 | Why? |
| Apolipoprotein A-II | 1 | 2002 | 2 | 0.02 | Why? |
| Imatinib Mesylate | 1 | 2006 | 327 | 0.02 | Why? |
| Benzamides | 1 | 2006 | 421 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.02 | Why? |
| Molecular Weight | 1 | 2002 | 249 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2017 | 3023 | 0.01 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Substrate Specificity | 1 | 2002 | 639 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Cell Proliferation | 1 | 2006 | 1973 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Particle Size | 1 | 2002 | 1052 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 1998 | 22971 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2006 | 3776 | 0.01 | Why? |
| Membrane Proteins | 1 | 2007 | 1733 | 0.01 | Why? |
| Drug Combinations | 1 | 2006 | 3852 | 0.01 | Why? |
| Protein Kinase Inhibitors | 1 | 2006 | 1585 | 0.01 | Why? |
| Binding Sites | 1 | 1987 | 6201 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2002 | 3786 | 0.01 | Why? |
| Peptide Fragments | 1 | 2002 | 2075 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Time Factors | 1 | 2002 | 31397 | 0.00 | Why? |